Estimating utilities from individual health preference data: a nonparametric Bayesian method

A fundamental benefit that is conferred by medical treatments is to increase the health-related quality of life (HRQOL) that is experienced by patients. Various descriptive systems exist to define a patient's health state, and we address the problem of assigning an HRQOL value to any given state in such a descriptive system. Data derive from experiments in which individuals are asked to assign their personal values to various health states. We construct a Bayesian model that takes account of various important aspects of such data. Specifically, we allow for the repeated measures feature that each individual values several different states, and the fact that individuals vary markedly in their valuations, with some people consistently providing higher valuations than others. We model the relationship between HRQOL and health state nonparametrically. We illustrate our method by using data from an experiment in which 611 individuals each valued up to six states in the descriptive system known as the SF-6D system. Although the SF-6D system distinguishes 18000 different health states, only 249 of these were valued in this experiment. We provide posterior inference about the HRQOL values for all 18000 states. Copyright 2005 Royal Statistical Society.

[1]  Anthony O'Hagan,et al.  Modelling SF-6D health state preference data using a nonparametric Bayesian method. , 2007, Journal of health economics.

[2]  Andrew Booth,et al.  A Review of the Use of Health Status Measures in Economic Evaluation , 1999, Journal of health services research & policy.

[3]  A. O'Hagan,et al.  Bayesian inference for non‐stationary spatial covariance structure via spatial deformations , 2003 .

[4]  M. Boyle,et al.  Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.

[5]  A. Gelman Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .

[6]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[7]  J. Brazier,et al.  A comparison of the EQ-5D and SF-6D across seven patient groups. , 2004, Health economics.

[8]  A. O'Hagan,et al.  Bayesian calibration of computer models , 2001 .

[9]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[10]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[11]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[12]  Stirling Bryan,et al.  An empirical comparison of EQ-5D and SF-6D in liver transplant patients. , 2003, Health economics.

[13]  M. Essink‐bot,et al.  Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. , 1999, Journal of health economics.

[14]  Wojtek J. Krzanowski,et al.  Principles of multivariate analysis : a user's perspective. oxford , 1988 .

[15]  G. Torrance Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[16]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.